Home Tags SinoMab

Tag: SinoMab

Business

Japan – SinoMab BioScience Limited Breakthrough Phase 1b POC Results for SM17 in Atopic Dermatitis

Editor -
0
Business

SinoMab BioScience preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy

-
0
Business

SinoMab Announces that IND Application of SM17 for the Treatment of Asthma was Approved by NAMP

Editor -
0
Business

SinoMab Submits another IND Application for SM17 for the Treatment of Atopic Dermatitis, Which was Accepted by NMPA CDE

Editor -
0
Business

SinoMab Announces IND Application of SM17 for the Treatment of Asthma was Accepted by NMPA CDE

-
0
Business

SinoMab Announces Appointment of Mr. Shanchun WANG as the President (China) of the Company

-
0
Business

SinoMab Received the Highest Subsidy from HKSTP

-
0
Business

SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.

-
0
Business

SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE

-
0
Business

SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE

-
0
Business

SinoMab Announces the Completion of Enrollment in Phase III Clinical Trial in China for its Flagship Product, SM03

-
0
Uncategorized

SinoMab, Sinovent and Everest Medicines Announce Licensing Agreement for Global Development and Commercialization of A Next-Generation BTK Inhibitor in Renal Diseases

-
0
Get $10 by answering a Simple Survey. Click Here